Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ArGEN-X grosses €40mm in Euronext Brussels IPO

Executive Summary

Floating on Euronext Brussels, Dutch antibody drug discovery company arGEN-X BV grossed €40mm ($54mm) in its IPO of 4.7mm shares at €8.50 (the bottom end of its €8.50-10.25 range). Belgian retail investors bought 6.2% of the stock, and existing arGEN-X backers committed to purchasing shares worth €10mm.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies